grepcent public filings, reorganized for comparison

DURYSTA — FDA application NDA211911

Application NDA211911 · type NDA · FDA status: approved · original approval 2020-03-04

Listed sponsor: ABBVIE · ABBV company profile · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

FDA application facts

ProductFDA-listed trade nameActive ingredientDosage formRouteStrengthMarketing statusTE codeRLD
001DURYSTABIMATOPROSTIMPLANTOPHTHALMIC10MCGPrescriptionnot listedYes

Product, form, strength, reference-drug and marketing-status fields: Drugs@FDA data files; TE and RLD fields: Orange Book data files. Retrieved 2026-08-07.

Orange Book patent and exclusivity listings

ListingProductDescriptive dateFlags/code
Patent 10441543001listed patent expiry date: 2026-12-19drug product
Patent 9149428001listed patent expiry date: 2026-12-19drug product
Patent 8206737001listed patent expiry date: 2027-04-07U-2759
Patent 7799336001listed patent expiry date: 2029-04-24drug product
Patent 8629185001listed patent expiry date: 2031-07-15drug substance, drug product
Patent 9492316001listed patent expiry date: 2034-10-31drug product
Patent 9980974001listed patent expiry date: 2034-10-31U-2759
NDA211911 FDA listing dates. Source: Drugs@FDA and FDA Orange Book.NDA211911 FDA listing dates. Source: Drugs@FDA and FDA Orange Book.NDA211911 FDA listing datesDescriptive regulatory dates only; no relationship to revenue or future sales is stated or implied.Source: Drugs@FDA and FDA Orange Book.Listed dateDated listing marker0.001.002.002020-03-041.002026-12-191.002027-04-071.002029-04-241.002031-07-151.002034-10-311.00

Patent and exclusivity dates are regulatory listings from the FDA Orange Book; no relationship to revenue or future sales is stated or implied.

Compound cross-links

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

Related pages

Sponsor company · FDA-approved application index

Peer clusters: Large-cap biopharma

Sources: Drugs@FDA · Orange Book · openFDA application record. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.